Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2012
08/16/2012US20120207729 Substituted benzoazole pde4 inhibitors for treating pulmonary and cardiovascular disorders
08/16/2012US20120207728 Epithelium-Improving Agent
08/16/2012US20120207726 Autism-associated biomarkers and uses thereof
08/16/2012US20120207709 Hbv antisense inhibitors
08/16/2012US20120207707 Methods and compositions for enhancing polypeptide production
08/16/2012US20120207703 Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating hcv infections
08/16/2012US20120207701 Bi-modal hyaluronate
08/16/2012US20120207700 Surface active agent compositions and methods for enhancing oxygenation, reducing bacteria and improving wound healing at a site of treatment
08/16/2012US20120207688 Rosacea Topical Skin Treatment Method and Formulation
08/16/2012US20120207687 Topical formulations of targeted nitroxide agents
08/16/2012US20120207682 Methods of treating macular edema using antiedema therapeutics
08/16/2012US20120207681 Chemical compositions to detect and treat amyloid in a patients brain and retina
08/16/2012US20120207679 Novel Heteroaryl Substituted Benzothiazoles
08/16/2012DE102012002428A1 Therapy-infusion solution, preferably e.g. macular degeneration therapy-infusion solution, polyneuropathy therapy-infusion solution and Parkinson's therapy-infusion solution, comprises hydroxyethyl acid based solution and Ginkgo biloba
08/16/2012DE102011000715A1 Wirkstoff für die Behandlung von entzündlichen Krankheitszuständen in der Mundhöhle Agent for the treatment of inflammatory disease states in the oral cavity
08/16/2012CA2841404A1 Treatment of angiogenesis disorders
08/16/2012CA2828059A1 Rorgammat inhibitors
08/16/2012CA2827380A1 Therapeutic compounds
08/16/2012CA2827157A1 Cathepsin c inhibitors
08/16/2012CA2827154A1 Methods for treating pulmonary hypertension
08/16/2012CA2827082A1 Methods of treating macular edema using antiedema therapeutics
08/16/2012CA2827069A1 Sildenafil-free base-containing film preparation and method for producing same
08/16/2012CA2827062A1 Storage-stable formulation of paracetamol in aqueous solution
08/16/2012CA2827027A1 Phenothiazine diaminium salts and their use
08/16/2012CA2827017A1 B-type plexin antagonists and uses thereof
08/16/2012CA2827005A1 Novel 1-(1-oxo-1,2,3,4-tetrahydroisoquinolin-7-yl)urea derivatives as n-formyl peptide receptor like-1 (fprl-1) receptor modulators
08/16/2012CA2826972A1 Treatment and prevention of cardiovascular disease and thrombosis
08/16/2012CA2826836A1 Antisense oligonucleotides
08/16/2012CA2826806A1 Permeation enhancers for topical formulations
08/16/2012CA2826774A1 Hepatitis c virus inhibitors
08/16/2012CA2826757A1 Substituted [(5h-pyrrolo[2,1-c][1,4]benzodiazepin-11-yl)piperazin-1-yl]-2,2-dimethylpropanoic acid compounds as dual activity h1 inverse agonists/5-ht2a antagonists
08/16/2012CA2826755A1 Hybrid opioid compounds and compositions
08/16/2012CA2826751A1 Processes for preparing quinoline compounds and pharmaceutical compositions containing such compounds
08/16/2012CA2826741A1 Novel antifungal composition
08/16/2012CA2826663A1 Therapeutic agent for diastolic congestive heart failure
08/16/2012CA2826387A1 Method of inhibiting hamartoma tumor cells
08/16/2012CA2826198A1 Pesticidal compositions and processes related thereto
08/16/2012CA2826183A1 Novel composition for the treatment of cystic fibrosis
08/16/2012CA2826146A1 Pesticidal compositions and processes related thereto
08/16/2012CA2826123A1 Compounds and methods for kinase modulation, and indications therefor
08/16/2012CA2826080A1 Administration regime for nitrocatechols
08/16/2012CA2825964A1 Forms of rifaximin and uses thereof
08/16/2012CA2825069A1 S1p modulating agents
08/16/2012CA2825053A1 Effervescent gamma-hydroxybutyric acid granules
08/16/2012CA2824101A1 N-[3-(5-amino-3,3a,7,7a-tetrahydro-1h-2,4-dioxa-6-aza-inden-7-yl)-phenyl]-amides as bace1 and/or bace2 inhibitors
08/15/2012EP2487243A2 RNAI modulation of RSV and therapeutic uses thereof
08/15/2012EP2487242A1 B-type plexin antagonists and uses thereof
08/15/2012EP2487241A1 RNAi agents and compositions useful as carp therapeutics
08/15/2012EP2487178A1 Pyrazolothiazole compound
08/15/2012EP2487177A1 Pyrazoloxazole compound
08/15/2012EP2487176A1 Macrocyclic integrase inhibitors for use in the treatment of feline immunodeficiency virus
08/15/2012EP2487175A1 Pharmaceutical product containing aromatic heterocyclic compound
08/15/2012EP2487174A2 Tricyclic and tetracyclic systems with activity on the central-nervous and vascular systems
08/15/2012EP2487171A1 Dihydrobenzopyran, thiochroman, tetrahydroquinoleine and tetrahydronaphthalene derivatives and their use in anti-cancer therapy
08/15/2012EP2487169A1 Compounds that inhibit (block) bitter taste in compositions and use thereof
08/15/2012EP2487168A1 Modulators of pharmacokinetic properties of therapeutics
08/15/2012EP2487167A1 Modulators of pharmacokinetic properties of therapeutics
08/15/2012EP2487166A1 Modulators of pharmacokinetic properties of therapeutics
08/15/2012EP2487165A1 Modulators of pharmacokinetic properties of therapeutics
08/15/2012EP2487164A1 Modulators of pharmacokinetic properties of therapeutics
08/15/2012EP2487163A1 Modulators of pharmacokinetic properties of therapeutics
08/15/2012EP2487162A1 Modulators of pharmacokinetic properties of therapeutics
08/15/2012EP2487161A1 Modulators of pharmacokinetic properties of therapeutics
08/15/2012EP2487159A1 RorgammaT inhibitors
08/15/2012EP2487157A1 Enantioselective synthesis method of 4-aminoalcoholquinoline derivatives and the use
08/15/2012EP2487156A1 Compounds for treatment of cell proliferative diseases
08/15/2012EP2487154A1 Pyrrolidinyl beta-amino amide-based inhibitors of dipeptidyl peptidase IV and methods
08/15/2012EP2487153A1 Substituted cyclopentanes having prostaglandin activity
08/15/2012EP2486942A1 Compositions comprising azelastine and methods of use thereof
08/15/2012EP2486931A1 Therapeutic agent for influenza virus infectious diseases
08/15/2012EP2486929A1 Therapeutic agent for tumor
08/15/2012EP2486928A1 Method for the treatment of amyloidoses
08/15/2012EP2486927A1 Treatment of Comorbid Premature Ejaculation and Erectile Dysfunction
08/15/2012EP2486926A1 Thiazolidinedione Analogues
08/15/2012EP2486924A2 Drugs and uses
08/15/2012EP2486923A1 Histone deacetylase (HDAC) inhibiting compounds and method of making same
08/15/2012EP2486922A1 Composition comprising benzoic acid in combination with organic acid preservatives as active components and use thereof
08/15/2012EP2486921A1 Reducing Side Effects of Tramadol
08/15/2012EP2486920A1 Stress-alleviating agent comprising plant-derived polyamine-containing extract as active ingredient
08/15/2012EP2486915A1 Topical pharmaceutical compositions comprising flurbiprofen and methylsulfonylmethane
08/15/2012EP2486913A1 Rapidly disintegrating oral film formulation for Olanzapin
08/15/2012EP2486060A1 Siglec 15 antibodies in treating bone loss-related disease
08/15/2012EP2486044A2 Antibacterial aminoglycoside analogs
08/15/2012EP2486042A1 Bicyclic heterocycles and their use as ccr2 receptor antagonists
08/15/2012EP2486041A1 Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
08/15/2012EP2486039A1 Purine derivatives useful as hsp90 inhibitors
08/15/2012EP2486038A1 Polymorphic and pseudopolymorphic forms of a pharmaceutical compound
08/15/2012EP2486037A2 8-ethyl-6-(aryl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders
08/15/2012EP2486034A1 Spirocyclic compounds as modulators of chemokine receptor activity
08/15/2012EP2486033A1 Compounds and compositions as modulators of gpr119 activity
08/15/2012EP2486030A1 Modulators of g protein-coupled receptor 88
08/15/2012EP2486026A1 Derivatives of di(phenylpropanoid) glycerol for the treatment of cancer
08/15/2012EP2486024A1 Phenyloxadiazole derivatives as pgds inhibitors
08/15/2012EP2486018A1 Substituted pyrazoles as estrogen receptor ligands
08/15/2012EP2486017A1 Indane-amine derivatives, their preparation and use as medicaments
08/15/2012EP2486016A1 Heterocycyl-substituted-alkylamino phenyl derivatives, their preparation and use as medicaments
08/15/2012EP2486014A1 Modulators of g protein-coupled receptor 88
08/15/2012EP2486011A1 Modulators of g protein-coupled receptor 88
08/15/2012EP2486010A2 Novel estrogen receptor ligands
08/15/2012EP2486009A1 2h-pyrrol-5-amine derivatives as alpha adrenergic receptor modulators
1 ... 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 ... 7860